AGP Picks View all

Advertising Press Releases: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Advertising Press Releases.

Press releases published on September 8, 2026

OptimizeRx to Participate in the 10th Annual Lake Street Best Ideas Growth Conference
Domestic Metals Commences Drill Program at Smart Creek Project, Montana
BrainsWay Reports Promising Pilot Study Results in Patients with Depression and Comorbid Early-Stage Alzheimer’s Disease Treated with Deep TMS™
Volatus Aerospace Qualifies Across All Five Streams of Canada’s Defence Drone Initiative Marketplace
Volatus Aerospace se qualifie dans les cinq volets du Marché de l’Initiative de drones de défense du Canada
Medicus Pharma Advances Transformation into a Precision Oncology-Led Biotechnology Company
ASML begins construction of new Eindhoven campus, strengthening its presence in the Brainport region
Transaction in Own Shares
Polar Power Reduces Pinnacle Bank Debt by $3 Million, from Approximately $4.7 Million to $1.667 Million; Expects Remaining Balance to Be Paid Down by End of September
A Single Filing Reveals Elon Musk's Plan to Make Artificial Intelligence a "Winner Take All" Game, Says Top AI Expert James Altucher
SPIRIT BLOCKCHAIN CAPITAL ANNOUNCES NAME CHANGE TO IMPAUER TECHNOLOGIES INC. AND NEW TRADING SYMBOLS
Generate Biomedicines Inc. to Participate in September Investor Conferences
4BIO Capital leads oversubscribed $33 Million Seed Financing of Cloverleaf Bio, Advancing Novel RNA-Based Cancer Therapeutics
Zenas BioPharma to Host Obexelimab IgG4-RD Investor Event
Lantronix CEO to Participate in Upcoming Investor and Industry Events
Robinson Unmanned R44 AIRTRUCK Demonstrates Offshore Cargo Capabilities at Acadiana Regional Airport in Louisiana
Microchip’s 1.2V Clock Buffers Link Latest SoCs and FPGAs with Higher Voltage Components
Invivyd to Participate in Upcoming September Investor Conferences
CoinShares Co-Founder and Non-Executive Director Daniel Masters Adopts Pre-Scheduled Trading Plan
Infex Therapeutics presents new Phase IIa data for RESP-X at ERS Congress 2026, providing further evidence on exploratory efficacy endpoints supporting progression to later stage development

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Advertising Press Releases

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.